Статті в журналах з теми "Adjuvant hormone therapy"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Adjuvant hormone therapy".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Boyages, John, and Ken W. Tiver. "ADJUVANT SYSTEMIC THERAPY IN BREAST CANCER PART 1: ADJUVANT HORMONE THERAPY." ANZ Journal of Surgery 62, no. 5 (May 1992): 354–63. http://dx.doi.org/10.1111/j.1445-2197.1992.tb07203.x.
Повний текст джерелаGupta, S., M. Singh, Amish Vora, G. Babu, M. Walia, V. Nautial, R. Saha, et al. "Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer." South Asian Journal of Cancer 07, no. 02 (April 2018): 142–45. http://dx.doi.org/10.4103/sajc.sajc_122_18.
Повний текст джерелаLatif, Asma, Alexander C. Small, Erin L. Moshier, Kerin B. Adelson, George Raptis, James H. Godbold, William K. Oh, and Matt D. Galsky. "Practice patterns in the use of adjuvant therapy for post-menopausal early-stage breast cancer in the pre- and post-Oncotype DX era." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e21032-e21032. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e21032.
Повний текст джерелаZeng, Erwei, Wei He, Jenny Bergqvist, and Kamila Czence. "Abstract P3-12-04: Extending therapy after 5-year adjuvant hormone therapy in breast cancer patients: A population-based study." Cancer Research 82, no. 4_Supplement (February 15, 2022): P3–12–04—P3–12–04. http://dx.doi.org/10.1158/1538-7445.sabcs21-p3-12-04.
Повний текст джерелаWiltshaw, E. "Adjuvant hormone therapy in ovarian cancer." Biomedicine & Pharmacotherapy 46, no. 4 (January 1992): 176. http://dx.doi.org/10.1016/0753-3322(92)90032-3.
Повний текст джерелаBlomqvist, Carl P., Inkeri Elomaa, and Pentti Rissanen. "Adjuvant Hormone Therapy in Breast Cancer." Annals of Medicine 24, no. 2 (January 1992): 91–96. http://dx.doi.org/10.3109/07853899209148333.
Повний текст джерелаKovalenko, E. I., I. B. Kononenko, A. V. Snegovoi, O. P. Grebennikova, and L. V. Manzyuk. "Adverse effects of adjuvant endocrine therapy." Medical Council, no. 10 (July 19, 2018): 64–69. http://dx.doi.org/10.21518/2079-701x-2018-10-64-69.
Повний текст джерелаLoibl, S., G. von Minckwitz, and M. Kaufmann. "Adjuvant hormone therapy following primary therapy for endometrial cancer." European Journal of Cancer 38 (September 2002): 41–43. http://dx.doi.org/10.1016/s0959-8049(02)00281-2.
Повний текст джерелаSlonimskaya, E. M., A. V. Doroshenko, P. V. Kazantseva, N. A. Tarabanovskaya, and R. Yu Vernadsky. "Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer." Tumors of female reproductive system 14, no. 3 (October 16, 2018): 48–54. http://dx.doi.org/10.17650/1994-4098-2018-14-3-48-54.
Повний текст джерелаCutolo, Maurizio. "SEX HORMONE ADJUVANT THERAPY IN RHEUMATOID ARTHRITIS." Rheumatic Disease Clinics of North America 26, no. 4 (November 2000): 881–95. http://dx.doi.org/10.1016/s0889-857x(05)70174-5.
Повний текст джерелаNeven, P. "ADJUVANT THERAPY FOR HORMONE-DEPENDENT BREAST CANCER." International Journal of Gynecologic Cancer 13, Suppl 1 (March 2003): 116.1–116. http://dx.doi.org/10.1136/ijgc-00009577-200303001-00433.
Повний текст джерелаKimmick, Gretchen, Roger Anderson, Fabian Camacho, Monali Bhosle, Wenke Hwang, and Rajesh Balkrishnan. "Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer." Journal of Clinical Oncology 27, no. 21 (July 20, 2009): 3445–51. http://dx.doi.org/10.1200/jco.2008.19.2419.
Повний текст джерелаMcArthur, H. L., and H. F. Kennecke. "Rationale for Extended Adjuvant Letrozole after Five Years of Tamoxifen in Postmenopausal Oestrogen Receptor–Positive Women with Early-Stage Breast Cancer." Current Oncology 12, no. 3 (September 1, 2005): 78–82. http://dx.doi.org/10.3390/curroncol12030003.
Повний текст джерелаJones, Kellie L., and Aman U. Buzdar. "A review of adjuvant hormonal therapy in breast cancer." Endocrine-Related Cancer 11, no. 3 (September 2004): 391–406. http://dx.doi.org/10.1677/erc.1.00594.
Повний текст джерелаKaisary, A. V., and M. Jarmulowicz. "Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)—Agonist Therapy in Prostate Cancer." UroOncology 3, no. 2 (June 2003): 51–62. http://dx.doi.org/10.1080/1561095031000148772.
Повний текст джерелаDitonno, Pasquale, Michele Battaglia, and Francesco Paolo Selvaggi. "Adjuvant Hormone Therapy after Radical Prostatectomy: Indications and Results." Tumori Journal 83, no. 2 (March 1997): 567–75. http://dx.doi.org/10.1177/030089169708300219.
Повний текст джерелаGiordano, Sharon H., Gabriel N. Hortobagyi, Shu-Wan C. Kau, Richard L. Theriault, and Melissa L. Bondy. "Breast Cancer Treatment Guidelines in Older Women." Journal of Clinical Oncology 23, no. 4 (February 1, 2005): 783–91. http://dx.doi.org/10.1200/jco.2005.04.175.
Повний текст джерелаVan Poppel, Hein. "Neoadjuvant and Adjuvant Hormone Therapy: How and When?" European Urology Supplements 7, no. 13 (December 2008): 747–51. http://dx.doi.org/10.1016/j.eursup.2008.09.001.
Повний текст джерелаBossi, Alberto. "Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?" European Urology Supplements 8, no. 12 (December 2009): 848–51. http://dx.doi.org/10.1016/j.eursup.2009.09.003.
Повний текст джерелаZlotta, Alexandre R., and Claude C. Schulman. "Neoadjuvant and adjuvant hormone therapy for prostate cancer." World Journal of Urology 18, no. 3 (June 16, 2000): 179–82. http://dx.doi.org/10.1007/s003450000119.
Повний текст джерелаKarakas, Yusuf, Serkan Akin, Omer Dizdar, and Sercan Aksoy. "Analysis of the Adjuvant Hormone Therapy Randomized Trial." Journal of Clinical Oncology 34, no. 17 (June 10, 2016): 2070. http://dx.doi.org/10.1200/jco.2015.65.4277.
Повний текст джерелаVoutsadakis, Ioannis A. "On Adjuvant Hormone Therapy in Epithelial Ovarian Cancer." Journal of Clinical Oncology 34, no. 17 (June 10, 2016): 2070–71. http://dx.doi.org/10.1200/jco.2015.66.3245.
Повний текст джерелаKimmick, G. G., F. Camacho, W. Hwang, and R. T. Anderson. "The relationship between adherence to adjuvant hormonal therapy and survival among low-income, insured women with primary breast cancer." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e11522-e11522. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e11522.
Повний текст джерелаThomas, Christian A. "Early-stage breast cancer patients reporting difficulty sleeping, mood issues, or pain are more likely to refuse adjuvant hormone therapy." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e12065-e12065. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12065.
Повний текст джерелаLigibel, Jennifer A., and Eric P. Winer. "The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer." Journal of the National Comprehensive Cancer Network 1, no. 2 (April 2003): 215–21. http://dx.doi.org/10.6004/jnccn.2003.0020.
Повний текст джерелаLove, Richard R., Nguyen Ba Duc, D. Craig Allred, Nguyen Cong Binh, Nguyen Van Dinh, Nguyen Ngoc Kha, Tran Van Thuan, et al. "Oophorectomy and Tamoxifen Adjuvant Therapy in Premenopausal Vietnamese and Chinese Women With Operable Breast Cancer." Journal of Clinical Oncology 20, no. 10 (May 15, 2002): 2559–66. http://dx.doi.org/10.1200/jco.2002.08.169.
Повний текст джерелаWiner, Eric P., Clifford Hudis, Harold J. Burstein, Antonio C. Wolff, Kathleen I. Pritchard, James N. Ingle, Rowan T. Chlebowski, et al. "American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004." Journal of Clinical Oncology 23, no. 3 (January 20, 2005): 619–29. http://dx.doi.org/10.1200/jco.2005.09.121.
Повний текст джерелаHe, Wei, Fang Fang, Catherine Varnum, Mikael Eriksson, Per Hall, and Kamila Czene. "Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer." Journal of Clinical Oncology 33, no. 20 (July 10, 2015): 2262–69. http://dx.doi.org/10.1200/jco.2014.59.3673.
Повний текст джерелаLin, C. M., J. Jaswal, T. Vandenberg, A. Tuck, and M. Brackstone. "Weakly hormone receptor– positive breast cancer and use of adjuvant hormonal therapy." Current Oncology 20, no. 6 (September 16, 2013): 612. http://dx.doi.org/10.3747/co.20.1598.
Повний текст джерелаGnant, Michael, Catherine Van Poznak, and Lowell Schnipper. "Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment." American Society of Clinical Oncology Educational Book, no. 37 (May 2017): 116–22. http://dx.doi.org/10.1200/edbk_177357.
Повний текст джерелаStrasser-Weippl, Kathrin, and Paul E. Goss. "Adjuvant endocrine therapy options in hormone-dependent breast cancer." European Journal of Cancer Supplements 3, no. 3 (October 2005): 247–54. http://dx.doi.org/10.1016/s1359-6349(05)80281-2.
Повний текст джерелаOvcaricek, Tanja, Iztok Takac, and Erika Matos. "Multigene expression signatures in early hormone receptor positive HER 2 negative breast cancer." Radiology and Oncology 53, no. 3 (September 24, 2019): 285–92. http://dx.doi.org/10.2478/raon-2019-0038.
Повний текст джерелаChia, S. K. L. "Clinical application and utility of genomic assays in early-stage breast cancer: key lessons learned to date." Current Oncology 25 (June 14, 2018): 125. http://dx.doi.org/10.3747/co.25.3814.
Повний текст джерелаGreene, Rebecca E., and Vivian Tsang. "Hormonal Therapy for the Treatment of Postmenopausal Breast Cancer Patients." Journal of Pharmacy Practice 21, no. 1 (February 2008): 36–45. http://dx.doi.org/10.1177/0897190008315055.
Повний текст джерелаMori, Ryutaro, and Yasuko Nagao. "The efficacy of second-line hormone therapy for recurrence during adjuvant hormone therapy for breast cancer." Therapeutic Advances in Medical Oncology 6, no. 2 (January 13, 2014): 36–42. http://dx.doi.org/10.1177/1758834013517734.
Повний текст джерелаSvahn, Tiffany H., and Robert W. Carlson. "Modest benefits of adjuvant chemotherapy in hormone receptor-positive breast cancer." Breast Cancer Online 9, no. 7 (May 16, 2006): 1–4. http://dx.doi.org/10.1017/s1470903106004378.
Повний текст джерелаBracken-Clarke, Dara B., Mairi W. Lucas, and Michaela J. Higgins. "Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer." Breast Care 12, no. 3 (2017): 138–44. http://dx.doi.org/10.1159/000477956.
Повний текст джерелаVarnier, Romain, Christophe Sajous, Solène de Talhouet, Colette Smentek, Julien Péron, Benoît You, Thibaut Reverdy, and Gilles Freyer. "Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives." Cancers 13, no. 19 (September 28, 2021): 4840. http://dx.doi.org/10.3390/cancers13194840.
Повний текст джерелаAdami, G., A. Fassio, A. Giollo, G. Orsolini, O. Viapiana, D. Gatti, and M. Rossini. "SAT0456 REAL-LIFE RISK OF FRACTURE AND TREATMENT PREVALENCE IN DRUG-INDUCED OSTEOPOROSIS IN ITALY USING A NEW ALGORITHM." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1185.1–1186. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2565.
Повний текст джерелаSemiglazov, V. F., V. Yu Lifanova, and V. S. Appolonova. "Adjuvant therapy in premenopausal women with hormone-dependent breast cancer." Medical Council, no. 19 (November 11, 2018): 73–75. http://dx.doi.org/10.21518/2079-701x-2018-19-73-75.
Повний текст джерелаShukurov, Farkhad I., and Farida M. Aiupova. "Role of adjuvant hormonal therapy in restoring reproductive function in women after endosurgical treatment of ovarian follicular cysts." Gynecology 23, no. 1 (March 21, 2021): 68–72. http://dx.doi.org/10.26442/20795696.2021.1.200441.
Повний текст джерелаSundar, Santhanam, and Micheal Ocathail. "Adjuvant Hormone Therapy After Prostate Radiation: Is This Data Torture?" Journal of Clinical Oncology 39, no. 20 (July 10, 2021): 2314–15. http://dx.doi.org/10.1200/jco.21.00013.
Повний текст джерелаHedin, T., C. Guo, and A. Nattinger. "Persistence with adjuvant hormone therapy in older breast cancer survivors." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 6032. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.6032.
Повний текст джерелаLiu, Feng, Daju Sun, Xueying Zhou, Youpeng Ding, Yanan Ma, Yi Hou, Xiangbo Kong, and Zhixin Wang. "Effect of adjuvant hormone therapy in patients with prostate cancer." Medicine 97, no. 50 (December 2018): e13145. http://dx.doi.org/10.1097/md.0000000000013145.
Повний текст джерелаStrasser-Weippl, Kathrin, Tanja Badovinac-Crnjevic, Lei Fan, and Paul E. Goss. "Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer." Breast 22 (August 2013): S171—S175. http://dx.doi.org/10.1016/j.breast.2013.07.033.
Повний текст джерелаEeles, Rosalind A., James P. Morden, Martin Gore, Janine Mansi, John Glees, Miklos Wenczl, Christopher Williams, et al. "Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer." Obstetrical & Gynecological Survey 71, no. 4 (April 2016): 223–24. http://dx.doi.org/10.1097/ogx.0000000000000308.
Повний текст джерелаKilickap, Saadettin, and Deniz Tural. "Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?" Journal of Clinical Oncology 34, no. 17 (June 10, 2016): 2069. http://dx.doi.org/10.1200/jco.2015.65.3683.
Повний текст джерелаHershman, Dawn L., Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, and Alfred I. Neugut. "Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients." Journal of Clinical Oncology 28, no. 27 (September 20, 2010): 4120–28. http://dx.doi.org/10.1200/jco.2009.25.9655.
Повний текст джерелаMontemurro, Filippo, and Massimo Aglietta. "Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy." Endocrine-Related Cancer 16, no. 4 (December 2009): 1091–102. http://dx.doi.org/10.1677/erc-09-0033.
Повний текст джерелаAngelopoulos, N., V. Barbounis, S. Livadas, D. Kaltsas, and G. Tolis. "Effects of estrogen deprivation due to breast cancer treatment." Endocrine-Related Cancer 11, no. 3 (September 2004): 523–35. http://dx.doi.org/10.1677/erc.1.00783.
Повний текст джерела